Welcome to our dedicated page for Icu Medical news (Ticker: ICUI), a resource for investors and traders seeking the latest updates and insights on Icu Medical stock.
ICU Medical reports news on its global medical-device business in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate-site and home-care settings. Company updates commonly cover quarterly results, fiscal guidance, GAAP and non-GAAP profitability measures, and revenue trends across the Consumables, Infusion Systems and Vital Care product lines.
Recurring announcements also include earnings-call schedules, investor conference participation and business changes that affect reported comparisons, including the completed divestiture of the IV Solutions business. The company’s news flow centers on product-line performance, margin trends, adjusted EBITDA, adjusted diluted earnings per share and management commentary on operating results.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
ICU Medical, Inc. (Nasdaq: ICUI) has announced the schedule for its first quarter 2023 earnings release and conference call. The earnings results will be published on May 8, 2023, at approximately 4:00 p.m. ET, followed by a conference call at 4:30 p.m. ET. Investors can access the call by dialing (877) 300-8521 and using conference ID 10177448. A live webcast of the call will also be available on the company's website, with a replay option provided afterward.
ICU Medical is recognized globally for its infusion systems and critical care products used in varied healthcare settings, underscoring its commitment to quality and innovation.
ICU Medical (Nasdaq:ICUI) announced participation in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum on March 22, 2023, at 7:30 a.m. PT (10:30 a.m. ET). The management will engage in one-on-one meetings on the same day. Investors can access the live webcast via the company's website, with availability for replay later.
ICU Medical specializes in infusion systems and critical care products, serving hospitals and home care settings globally. The company is headquartered in San Clemente, California, focusing on quality and innovation.
ICU Medical, Inc. (Nasdaq:ICUI) reported significant financial results for Q4 2022, with revenues reaching $578 million, up from $340.5 million year-over-year. Despite this strong revenue growth, the company experienced a GAAP net loss of $(15.5 million) or $(0.65 per diluted share), contrasting with a net income of $19.9 million or $0.91 per diluted share in Q4 2021. The GAAP gross margin declined to 30% from 37% a year prior. Adjusted diluted EPS was $1.60, down from $1.82. The company expects a net loss between $(73) million and $(37) million for FY 2023, with adjusted EBITDA forecasted between $375 million and $425 million.
ICU Medical, a leader in medical products, will present at the Raymond James 44th Annual Institutional Investors Conference in Orlando, Florida, from March 5-8, 2023. The presentation is scheduled for March 6, 2023, at 8:00 a.m. PT (11:00 a.m. ET). Management will also engage in one-on-one meetings on the same day. The presentation will be available via a live webcast on the company's website, allowing for future replays. ICU Medical specializes in infusion systems and critical care products, catering to diverse healthcare environments.
ICU Medical, Inc. (Nasdaq:ICUI) has announced the timing of its fourth quarter 2022 earnings release and conference call. The results will be disclosed on February 27, 2023, at around 4:00 p.m. ET, followed by a conference call at 4:30 p.m. ET. Investors can join the call by phone at (877) 300-8521 with conference ID 10174731 or via webcast on the company's website. ICU Medical is recognized for its innovative medical products, particularly in infusion systems and critical care products. This earnings announcement is crucial for stakeholders looking to gauge the company's performance and future outlook.